299 related articles for article (PubMed ID: 1967441)
1. Randomisation and baseline comparisons in clinical trials.
Altman DG; Doré CJ
Lancet; 1990 Jan; 335(8682):149-53. PubMed ID: 1967441
[TBL] [Abstract][Full Text] [Related]
2. The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals.
Schulz KF; Chalmers I; Altman DG; Grimes DA; Doré CJ
Online J Curr Clin Trials; 1995 Aug; Doc No 197():[81 paragraphs]. PubMed ID: 8542098
[TBL] [Abstract][Full Text] [Related]
3. In the dark: the reporting of blinding status in randomized controlled trials.
Montori VM; Bhandari M; Devereaux PJ; Manns BJ; Ghali WA; Guyatt GH
J Clin Epidemiol; 2002 Aug; 55(8):787-90. PubMed ID: 12384193
[TBL] [Abstract][Full Text] [Related]
4. Randomisation to protect against selection bias in healthcare trials.
Kunz R; Vist G; Oxman AD
Cochrane Database Syst Rev; 2007 Apr; (2):MR000012. PubMed ID: 17443633
[TBL] [Abstract][Full Text] [Related]
5. Assessing blinding in randomised controlled trials of acupuncture: challenges and recommendations.
Hopton AK; Macpherson H
Chin J Integr Med; 2011 Mar; 17(3):173-6. PubMed ID: 21359917
[TBL] [Abstract][Full Text] [Related]
6. Randomisation in clinical trials.
Beller EM; Gebski V; Keech AC
Med J Aust; 2002 Nov; 177(10):565-7. PubMed ID: 12429008
[No Abstract] [Full Text] [Related]
7. The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies.
Chan S; Bhandari M
J Bone Joint Surg Am; 2007 Sep; 89(9):1970-8. PubMed ID: 17768194
[TBL] [Abstract][Full Text] [Related]
8. Randomisation and baseline characteristics in clinical trials.
Moscucci M
Lancet; 1990 Apr; 335(8696):1040-1. PubMed ID: 1970095
[No Abstract] [Full Text] [Related]
9. The matching quality of experimental and control interventions in blinded pharmacological randomised clinical trials: a methodological systematic review.
Bello S; Wei M; Hilden J; Hróbjartsson A
BMC Med Res Methodol; 2016 Feb; 16():18. PubMed ID: 26873063
[TBL] [Abstract][Full Text] [Related]
10. Mega-trials: methodological issues and clinical implications.
Charlton BG
J R Coll Physicians Lond; 1995; 29(2):96-100. PubMed ID: 7595900
[TBL] [Abstract][Full Text] [Related]
11. Unequal group sizes in randomised trials: guarding against guessing.
Schulz KF; Grimes DA
Lancet; 2002 Mar; 359(9310):966-70. PubMed ID: 11918933
[TBL] [Abstract][Full Text] [Related]
12. The landscape and lexicon of blinding in randomized trials.
Schulz KF; Chalmers I; Altman DG
Ann Intern Med; 2002 Feb; 136(3):254-9. PubMed ID: 11827510
[No Abstract] [Full Text] [Related]
13. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
Fergusson D; Glass KC; Waring D; Shapiro S
BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
[TBL] [Abstract][Full Text] [Related]
14. Risk of selection bias in randomised trials.
Kahan BC; Rehal S; Cro S
Trials; 2015 Sep; 16():405. PubMed ID: 26357929
[TBL] [Abstract][Full Text] [Related]
15. Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa.
Ndounga Diakou LA; Ntoumi F; Ravaud P; Boutron I
Trials; 2017 Jul; 18(1):291. PubMed ID: 28676066
[TBL] [Abstract][Full Text] [Related]
16. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology.
Schulz KF; Grimes DA; Altman DG; Hayes RJ
BMJ; 1996 Mar; 312(7033):742-4. PubMed ID: 8605459
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of clinical studies of the efficacy of therapeutic apheresis.
Vamvakas EC
J Clin Apher; 2000; 15(1-2):6-17. PubMed ID: 10767048
[No Abstract] [Full Text] [Related]
18. Are current standards of reporting quality for clinical trials sufficient in addressing important sources of bias?
Mills EJ; Ayers D; Chou R; Thorlund K
Contemp Clin Trials; 2015 Nov; 45(Pt A):2-7. PubMed ID: 26232560
[TBL] [Abstract][Full Text] [Related]
19. Fables or foibles: inherent problems with RCTs.
Rosner A
J Manipulative Physiol Ther; 2003 Sep; 26(7):460-7. PubMed ID: 12975633
[No Abstract] [Full Text] [Related]
20. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
